Page 899 - Cardiac Nursing

M
P
p86
6 A
P
75
75
g
e 8
75.
qxd
1-8
75.
0
009
8:3
9/0
9/2
LWBK340-c38_38_p861-875.qxd 09/09/2009 08:36 AM Page 875 Aptara
LWB K34 0-c 38_ p86 1-8 75. qxd 0 9/0 9/2 009 0 0 8:3 6 A M P a a g e 8 75 Apt ara
38_
L L LWB
K34
ara
Apt
K34
0-c
C HAPTER 38 / Obesity: An Overview of Assessment and Treatment 875
S. Davidson (Eds.), Behavioral medicine: Changing health lifestyles (pp. 123. Zhao, Y., & Encinosa, W. (2007). Bariatric surgery Utilization and out-
410–452). New York: Brunner/Mazel. comes in 1998 and 2004 (Statistical Brief No. 23). Rockville, MD:
98. Glasgow, R. E., Goldstein, M. G., Ockene, J. K., et al. (2004). Translat- Agency for Healthcare Research and Quality.
ing what we have learned into practice: Principles and hypotheses for in- 124. Buchwald, H., & Williams, S. E. (2004). Bariatric surgery worldwide
terventions addressing multiple behaviors in primary care. American 2003. Obesity Surgery, 14(9), 1157–1164.
7
Journal of Preventive Medicine, 27(2, Suppl. 1), 88–101. 125. Elder, K. A., & Wolfe, B. M. (2007). Bariatric surgery: A review of pro-
7
99. Rubak, S., Sandbaek, A., Lauritzen, T., et al. (2005). Motivational inter- cedures and outcomes. Gastroenterology, 132(6), 2253–2271.
viewing: A systematic review and meta-analysis. British Journal of General 126. Christou, N. V., Sampalis, J. S., Liberman, M., et al. (2004). Surgery de-
Practice, 55(513), 305–312. creases long-term mortality, morbidity, and health care use in morbidly
100. Smith West, D., DiLillo, V., Burzac, Z., et al. (2007). Motivational in- obese patients. Annals of Surgery, 240(3), 416–423.
terviewing improves weight loss in women with type 2 diabetes. Diabetes 127. Buchwald, H., Avidor, Y., Braunwald, E., et al. (2004). Bariatric surgery:
Care, 30(5), 1081–1087. A systematic review and meta-analysis. JAMA, 292(14), 1724–1737.
101. Hoy, M., Lubin, M., Grosvenor, M., et al. (2005). Development and use 128. Sjostrom, L., Narbro, K., Sjostrom, C. D., et al. (2007). Effects of
of a motivational action plan for dietary behavior change using a patient- bariatric surgery on mortality in Swedish obese subjects. New England
centered counseling approach. Topics in Clinical Nutrition, 20(2), Journal of Medicine, 357(8), 741–752.
7
7
118–126. 129. Wing, R. R., & Hill, J. O. (2001). Successful weight loss maintenance.
102. Carels, R. A., Darby, L., Cacciapaglia, H. M., et al. (2007). Using moti- Annual Review of Nutrition, 21, 323–341.
vational interviewing as a supplement to obesity treatment: A stepped- 130. Wing, R. R., Tate, D. F., Gorin, A. A., et al. (2006). A self-regulation
6
care approach. Health Psychology, 26(3), 369–374. program for maintenance of weight loss. New England Journal of Medi-
6
103. Heshka, S., Anderson, J. W., Atkinson, R. L., et al. (2003). Weight loss cine, 355(15), 1563–1571.
with self-help compared with a structured commercial program: A ran- 131. Hill, J. O., Thompson, H., & Wyatt, H. (2005). Weight maintenance:
domized trial. JAMA, 289(14), 1792–1798. What’s missing? Journal of the American Dietetic Association, 105(5,
104. Tate, D. F., Jackvony, E. H., & Wing, R. R. (2006). A randomized trial Suppl. 1), S63–S66.
comparing human e-mail counseling, computer-automated tailored 132. Perri, M. G., & Foreyt, J. P. (2004). Preventing weight regain after
counseling, and no counseling in an Internet weight loss program. weight loss. In G. A. Bray & C. Bouchard (Eds.), Handbook of obesity:
Archives of Internal Medicine, 166, 1620–1625. Clinical applications (2nd ed., pp. 185–199). New York: Marcel Dekker.
6
6
105. Weinstein, P. K. (2006). A review of weight loss programs delivered via 133. Befort, C. A., Stewart, E. E., Smith, B. K., et al. (2008). Weight mainte-
the Internet. Journal of Cardiovascular Nursing, 21(4), 251–258. nance, behaviors and barriers among previous participants of a univer-
106. Counterweight Project Team. (2005). Obesity impacts on general prac- sity-based weight control program. International Journal of Obesity,
tice appointments. Obesity Research, 13(8), 1442–1449. 32(3), 519–526. (Advance online publication December 4, 2007, DOI:
107. Counterweight Project Team. (2006). Nurse-led weight management: 10.1038/sj.ijo.0803769.)
The Counterweight Programme. Endocrine Abstracts, 11, S101. 134. Donnelly, J. E., Smith, B., Jacobsen, D. J., et al. (2004). The role of ex-
108. Kramer, M. K., Miller, R. G., Venditti, E. M., et al. (2008). DPP and the ercise for weight loss and maintenance. Best Practice & Research. Clinical
real world: Translating the Diabetes Prevention Program lifestyle inter- Gastroenterology, 18(6), 1009–1029.
V
V
vention into primary care practice. Under review. 135. Villanova, N., Pasqui, F., Burzacchini, S., et al. (2006). A physical activity
109. Aldana, S. G., Barlow, M., Smith, R., et al. (2005). The Diabetes Pre- program to reinforce weight maintenance following a behavior program in
vention Program: A worksite experience. American Association of Occu- overweight/obese subjects. International Journal of Obesity, 30(4),
pational Health Nurses Journal, 53(11), 499–505. 697–703.
110. Bray, G. A., & Greenway, F. L. (2007). Pharmacological treatment of the 136.Rucker, D., Padwal, R., Li, S. K., et al. (2007). Long term pharma-
overweight patient. Pharmacological Reviews, 59(2), 151–184. cotherapy for obesity and overweight: Updated meta-analysis. BMJ,
111. Palamara, K. L., Mogul, H. R., Peterson, S. J., et al. (2006). Obesity: New 335(7631), 1194–1199.
4
4
perspectives and pharmacotherapies. Cardiology in Review, 14(5), 238–258. 137. Richelsen, B., Tonstad, S., Rossner, S., et al. (2007). Effect of orlistat on
112. Klein, S. (2004). Long-term pharmacotherapy for obesity. Obesity Re- weight regain and cardiovascular risk factors following a very-low-energy
search,12(Suppl.), S163–S166. diet in abdominally obese patients: A 3-year randomized, placebo-
113. Padwal, R. S., & Majumdar, S. R. (2007). Drug treatments for obesity: controlled study. Diabetes Care, 30(1), 27–32.
Orlistat, sibutramine, and rimonabant. Lancet, 369(9555), 71–77. 138. Franz, M. J., Vanwormer, J. J., Crain, A. L., et al. (2007). Weight-loss
114. Li, Z., Maglione, M., Tu, W., et al. (2005). Meta-analysis: Pharmaco- outcomes: A systematic review and meta-analysis of weight-loss clinical
logic treatment of obesity. Annals of Internal Medicine, 142(7), trials with a minimum 1-year follow-up. Journal of the American Dietetic
7
532–546. Association, 107(10), 1755–1767.
7
115. Osei-Hyiaman, D., DePetrillo, M., Pacher, P., et al. (2005). Endo- 139. Klem, M. L., Wing, R. R., McGuire, M. T., et al. (1997). A descrip-
cannabinoid activation at hepatic CB1 receptors stimulates fatty acid tive study of individuals successful at long-term maintenance of sub-
6
6
synthesis and contributes to diet-induced obesity. Journal of Clinical In- stantial weight loss. American Journal of Clinical Nutrition, 66(2),
vestigation, 115(5), 1298–1305. 239–246.
116. Devane, W. A., Hanus, L., Breuer, A., et al. (1992). Isolation and struc- 140. Wyatt, H. R., Phelan, S., Wing, R. R., et al. (2005). Lessons from pa-
ture of a brain constituent that binds to the cannabinoid receptor. Sci- tients who have successfully maintained weight loss. Obesity Manage-
ence, 258, 1946–1949. ment, 1(2), 56–61.
117. Despres, J.-P., Golay, A., Sjostrom, L., et al. (2005). Effects of rimona- 141. Raynor, H. A., Jeffery, R. W., Phelan, S., et al. (2005). Amount of food
bant on metabolic risk factors in overweight patients with dyslipidemia. group variety consumed in the diet and long-term weight loss mainte-
New England Journal of Medicine, 353(20), 2121–2134. nance. Obesity Research, 13(5), 883–890.
118. Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., et al. (2005). Effects of 142. Gorin, A. A., Phelan, S., Wing, R. R., et al. (2004). Promoting long-term
the cannabinoid-1 receptor blocker rimonabant on weight reduction and weight control: Does dieting consistency matter? International Journal of
cardiovascular risk factors in overweight patients: 1-year experience from Obesity, 28(2), 278–281.
the RIO-Europe study. Lancet, 365(9468), 1389–1397. 143. Wyatt, H. R., Grunwald, G. K., Mosca, C. L., et al. (2002). Long-term
119. Christensen, R., Kristensen, P. K., Bartels, E. M., et al. (2007). Efficacy weight loss and breakfast in subjects in the National Weight Control
and safety of the weight-loss drug rimonabant: A meta-analysis of ran- Registry. Obesity Research, 10(2), 78–82.
domised trials. Lancet, 370(9600), 1706–1713. 144. Raynor, D. A., Phelan, S., Hill, J. O., et al. (2006). Television viewing
120. Harris, G. (2008). FDA requiring suicide studies in drug trials. New and long-term weight maintenance: Results from the National Weight
York Times, Retrieved February 1, 2008, from http://www.nytimes.com/ Control Registry. Obesity,14(10), 1816–1824.
2008/01/24/washington/24fda.html?pagewanted 2&_r 2&ei 5070 145. Butryn, M. L., Phelan, S., Hill, J. O., et al. (2007). Consistent self-
&en 1cec78d043161c41&ex 1201842000&emc eta1 monitoring of weight: A key component of successful weight loss main-
121. Buchwald, H. (2005). The future of bariatric surgery. Obesity Surgery, tenance. Obesity, 15(12), 3091–3096.
15(5), 598–605. 146. Linde, J. A., Jeffery, R. W., French, S. A., et al. (2005). Self-weighing in
122. Steinbrook, R. (2004). Surgery for severe obesity. New England Journal weight gain prevention and weight loss trials. Annals of Behavioral Med-
of Medicine, 350(11), 1075–1079. icine, 30(3), 210–216.